PYC-002

N/A

Report date: 2023/09/08 17:42:18

NME

Base Information

Drug NamePYC-002

Drug Alias NamePYC-002

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)

Mechanisms of ActionSH3 and multiple ankyrin repeat domains protein 3 inhibitors

TargetsSH3 and multiple ankyrin repeat domains protein 3

Therapy Area/IndicationsPhelan-McDermid syndrome

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPYC Therapeutics LLC

China Registration ClassN/A

Develop Information

Active CompaniesPYC Therapeutics LLC

Inactive CompaniesN/A

Active IndicationsPhelan-McDermid syndrome

Inactive IndicationsN/A

Other Information

ATC CodeN/A